Nucleosides with anti-hepatitis B virus activity

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 3, 2001, Pages 503-505

[No Author Info available]

Author keywords

Antiviral agents; Azido nucleosides; Fluoro nucleosides; Hepatitis B virus; Lamivudine; Nucleosides

Indexed keywords

ANTIVIRUS AGENT; AZIDONUCLEOSIDE; BETA LEVO 2' AZIDO 2' 3' DIDEOXY FLUOROCYTOSINE; BETA LEVO 3' AZIDO 2' 3' DIDEOXY FLUOROCYTOSINE; DNA POLYMERASE; FLUCYTOSINE; FLUORONUCLEOSIDE; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMISTRY; DRUG ACTIVITY; DRUG POTENCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; PATENT;

EID: 0035117905     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.3.503     Document Type: Article

References (9)

1. New antivirals - Mechanism of action and resistance development
2. Antiretroviral therapy: State of the HAART
3. New trends in antiretroviral therapy of HIV infection
4. Antiretroviral therapy of HIV-1 infection: Established treatment strategies and new therapeutic options
5. Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immuno-deficiency virus activity of nucleoside reverse transcriptase inhibitors
6. Effect of lamivudine on replication of hepatitis B virus in HIV infected patients
7. Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine
8. New drugs - Reports of new drugs recently approved by the FDA: Lamivudine
9. as-Triazine derivatives with potential therapeutic action. Part 22. A simplified method for the synthesis of 1,2,4-triazole nucleosides and 1,2,4-triazine nucleosides